Inhibrx, Inc. (INBX)
NASDAQ: INBX · IEX Real-Time Price · USD
12.88
-0.10 (-0.77%)
At close: Jul 19, 2024, 4:00 PM
12.89
+0.01 (0.08%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Inhibrx Market Cap
Inhibrx has a market cap or net worth of $186.45 million as of July 22, 2024.
Market Cap
186.45M
Enterprise Value
189.13M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.88
Market Cap Chart
Since the IPO on August 19, 2020, Inhibrx's market cap has decreased from $606.13M to $186.45M, a decrease of -69.24%. That is a compound annual growth rate of -25.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 172.30M | -71.57% |
| Aug 19, 2020 | 606.13M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 189.47M |
| Greenwich LifeSciences | 189.01M |
| XBiotech | 188.84M |
| Seres Therapeutics | 187.67M |
| Outlook Therapeutics | 187.48M |
| EDAP TMS | 186.82M |
| Ventyx Biosciences | 186.18M |
| Biomea Fusion | 185.11M |